Treatment of Traumatic Brain Injury in Rats with Transplantation of Human Amniotic Cells
Lu Yi,Hui Guo-zhen,Wu Zhi-yuan,Guo Li-he,Ji Xun-he,Wu Xin
DOI: https://doi.org/10.1097/00029330-200611010-00014
2006-01-01
Abstract:Traumatic brain injury (TBI), which is an important reason of human mortality and morbidity in industrialized countries, still cannot be treated effectively. Since the self-repair capacity of brain is limited, cellular transplantation in TBI may be a therapeutic option. Human amniotic cells (HACs) from fertilized ovum are able to differentiate into all the tissues of the body. They can not only express the markers of neuronal and glial cells1 but also synthesize and release the neurotrophic factors.2 Moreover, transplanted HACs rarely induce immunologic rejection.3,4 In this study, we investigated whether HAC cultures conditioned by traumatic brain tissue extracts can acquire the phenotype of neuron, and examined the effects of transplanted HACs on the affected hindlimb of rats with TBI. METHODS Cell separation and culture The separated amnion was dissected into several pieces, treated with 0.25% trypsin (GibcoBRL) at 37°C for 15 minutes, and repeated for three times. Then the isolated HACs were collected by centrifugation. After cellular viability was assessed by trypan blue, HACs were cultured in RPMI1640 medium (GibcoBRL) supplemented with 10% fetal bovine serum (FBS, GibcoBRL, USA). After 48 hours, the nonadherent HACs were discarded. Cell fluorescence labeling Hoechst33342 (Sigma, USA) was mixed with RPMI1640 medium to yield a final concentration of 5 μg/ml. After being labelled with Hoechst33342 for 30 minutes at 37°C, the HACs were collected and rinsed for three times by phosphate-buffered saline (PBS). Animal models Adult female Sprague-Dawley rats (200 - 350 g) were obtained from Shanghai Experimental Animals Institute of Chinese Academy of Sciences. Improved Feeney's weight drop technique was made by allowing a 20 g weight to fall onto the rod from a height of 30 cm. After trauma, the bone flap was immediately replaced and sealed with dental cement. The rats of sham TBI group were anesthetized and received craniotomies without weight drop injury. Cell conditioned culture HACs were seeded at 105 cells/ml and treated with RPMI1640 containing 20% TBI tissue extract. After 7-day co-culture, HACs were stained with hematoxylin and eosin (HE) and processed for immunocytochemistry with mouse monoclonal antibody microtubule-associated protein 2 (MAP2, Sigma, USA). Cell transplantation The rats were reanesthetized 24 hours after the injury. The HACs were implanted into both the center and margin of the injured site by a 5-μl microsyringe and Narishige stereotactic frame (Japan). Then, the rats were divided into treatment group (TBI+HACs, 8 rats), control group (TBI+PBS, 8 rats), and sham TBI group (7 rats). Assessment of affected hindlimb Rats were pretrained to traverse an elevated narrow beam which had 4 steel pegs equally spaced to a dark goal box at the end of the beam three days before the injury. Footslips with the affected hindlimb was counted. Histological analysis After 28-day evaluation of footslips, the brain sections were made for fluorescence microscopy, and morphological and immunohistochemical analyses. Statistics analysis Footslips at each time points were analyzed by Kruskal-Wallis H test, data were expressed as mean ± standard deviation (SD). Statistical significance was set at P<0.05. RESULTS Cell morphology Most adherent HACs were round or oval. After being stained with HE, the cytoplasm was pink and the nucleus was blue. Under a fluorescence microscope, most nuclei of Hoechst33342-labeled HACs glowed blue. Three days after being co-cultured with RPMI1640 containing 20% TBI tissue extract, the cytoplasm of HACs retracted towards the nucleus. On day 7, some of the HACs formed processes. After being stained with HE, the morphological changes of HACs were apparent. Some HACs were pyramidal, connecting with each other via a few processes (Fig. A). To assess the neuronal differentiation, we examined the expression of MAP2 in the HACs. The cells expressed MAP2 were stained brown with a neural morphology, extending processes (Fig. B).Fig.: Under a light microscope, HACs showed a pyramidal morphology and neurite-like processes. A: Stained with HE, original magnification × 100. B: Immunostained with antibody against MAP2 (SABC), original magnification×200.Histological analysis Under a fluorescence microscope, Hoechst33342-labeled HACs showed blue fluorescence around the injection site and the transplantation trajectory, indicating that the HACs survived in the brain of the TBI rats up to 4 weeks after the transplantation. Grafted HACs under a fluorescence microscope were less than those under a light microscope, which suggested that the number of Hoechst33342-labeled HACs decreased over time. Immunohistochemistry of the brain sections revealed that some grafted HACs in the treatment group were reactive to MAP2, confirming that the implanted HACs can express the specific antigen of the neuron. Footslips of affected hindlimb The transplanted HACs in the treatment group yielded less footslips than those of the control group (P<0.05), but had more footslips than those of the sham TBI group (P<0.05), showing that transplanting HACs into TBI rats can improve the function of affected hindlimb. However, the recovery was not complete. DISCUSSION HACs have pluripotential characteristic of being able to differentiate, at least in part, into other tissues.1,5,6 They do not express HLA-class II antigen but slightly express HLA-class I antigen, indicating a lower risk of graft-versus-host reaction after transplantation.6 It has been reported that HACs can survive in severe combined immunodeficiency mice, Hartley guinea pigs, and bonnet monkeys. In this study, Hoechst33342-labeled HACs can be examined by fluorescence microscopy, verifying that the grafted HACs can survive in rats' brain for at least 4 weeks. HACs not only express the markers of neuron such as neurofilament proteins (NF) and MAP2, but also display positive immunoreactivity to glial fibrillary acidic protein (GFAP), a marker of glia.1 HACs have the capacity to synthesize and release brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), nerve growth factor (NGF), and unidentified neurotrophic factors,2 suggesting that the cells may supply neurotrophic factors in the amniotic fluid. They can also synthesize prostaglandin E2, laminin and insulin-like growth factor,7,8 contributing to regeneration of nervous tissue. Five weeks after being transplanted into the ischemic hippocampus, a majority of the grafted HACs were clustered at the injection site, or migrated into the CA1 region, and were stained with the antibody to MAP2.9 These results indicate that the HACs have therapeutic potential against brain damage, and demonstrate that HACs can acquire the neuronal phenotype both in vivo and in vitro, improving the function of the affected hindlimb in TBI rats. Acknowledgements: We thank Mr. JIANG Zhi-hua and Mr. HUANG Qin for their technical assistance.